510(k) K213936
K213936 is an FDA 510(k) premarket notification submitted by DiaSorin, Inc. for the device "LIAISON MeMed BV, LIAISON MeMed BV Control Set". The FDA issued a decision of Substantially Equivalent on Jul 14, 2022. The device falls under product code QPS (Immunoassay For Host Biomarkers Of Infection), a Class II device regulated under 21 CFR 866.3215. DiaSorin, Inc. has 73 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jul 14, 2022
- Date Received
- Dec 16, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Immunoassay For Host Biomarkers Of Infection
- Device Class
- Class II
- Regulation Number
- 866.3215
- Review Panel
- MI
- Submission Type
- 510(k)
A semi-quantitative immunoassay that quantifies the relative levels of host response proteins isolated from serum or similar specimens.
Need the full FDA record for DiaSorin, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.